Top compounds associated with response to SLC16A9


Feature Type Standardized
Nominal ANOVA
mRNA regorafenib CTRPv2 pan-cancer AAC 0.016 0.7
mRNA TAE684 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA OSI-027 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.014 0.7
mRNA EX-527 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA SL 0101-1 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA Compound 1541A CTRPv2 pan-cancer AAC -0.016 0.7
Download CSV